Ireland Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2017

Global Markets Direct, December 2011, Pages: 67

Ireland Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2017

Summary

”Ireland Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2017”, a new report by Global Markets Direct, provides key market data on the Ireland Diabetes Care Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within two market categories – Glucose Monitoring and Insulin Delivery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on key recent developments.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Global Markets Direct’s team of industry experts.

Scope

- Market size and company share data for Diabetes Care Devices market categories – Glucose Monitoring and Insulin Delivery.
- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within two market categories. Data from 2003 to 2010, forecast forward for 7 years to 2017.
- 2010 company shares and distribution shares data for each of the two market categories.
- Global corporate-level profiles of key companies operating within the Ireland Diabetes Care Devicesmarket.
- Key players covered include F. Hoffmann-La Roche Ltd., LifeScan, Inc., Sanofi, Novo Nordisk A/S, Eli Lilly and Company, Bayer HealthCare AG and others.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the Ireland Diabetes Care Devices competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

1
1

1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What is This Report About?
3 Diabetes Care Devices In Ireland
3.1 Diabetes Care Devices, Ireland, Overall Revenue ($m), USD Actual, 2003-2017
3.2 Diabetes Care Devices, Ireland, Category Volume (Units), 2003-2017
3.3 Diabetes Care Devices, Ireland, Company Share (2009-2010)
4 Glucose Monitoring In Ireland
4.1 Glucose Monitoring Overall Revenue (2003-2017)
4.1.1 Blood Glucose Meters Revenue (2003-2017)
4.2 Glucose Monitoring Overall Volume (2003-2017)
4.2.1 Blood Glucose Meters Volume (2003-2017)
4.3 Glucose Monitoring Average Price (2003-2017)
4.4 Glucose Monitoring Distribution Share (2009-2010)
4.5 Glucose Monitoring, Ireland, Company Share (2009-2010)
5 Insulin Delivery In Ireland
5.1 Insulin Delivery Overall Revenue (2003-2017)
5.1.1 Insulin Pens Revenue (2003-2017)
5.1.2 Insulin Pumps Revenue (2003-2017)
5.2 Insulin Delivery Overall Volume (2003-2017)
5.2.1 Insulin Pens Volume (2003-2017)
5.2.2 Insulin Pumps Volume (2003-2017)
5.3 Insulin Delivery Average Price (2003-2017)
5.4 Insulin Delivery Distribution Share (2009-2010)
5.5 Insulin Delivery, Ireland, Company Share (2009-2010)
6 Overview of Key Companies in Ireland Diabetes Care Devices Market
6.1 F. Hoffmann-La Roche Ltd.
6.1.1 Company Overview
6.2 LifeScan, Inc.
6.2.1 Company Overview
6.3 Sanofi
6.3.1 Company Overview
6.4 Novo Nordisk A/S
6.4.1 Company Overview
6.5 Eli Lilly and Company
6.5.1 Company Overview
6.6 Bayer HealthCare AG
6.6.1 Company Overview
6.7 Abbott Laboratories
6.7.1 Company Overview
6.8 Medtronic, Inc.
6.8.1 Company Overview
6.9 NIPRO CORPORATION
6.9.1 Company Overview
6.10 Becton, Dickinson and Company
6.10.1 Company Overview
6.11 Terumo Corporation
6.11.1 Company Overview
6.12 Animas Corporation
6.12.1 Company Overview
7 APPENDIX
7.1 Global Markets Direct Research Methodology
7.2 Definitions of Markets Covered in the Report
7.2.1 Diabetes Care Devices
7.3 Secondary Research
7.4 Primary Research
7.5 Models
7.6 Forecasts
7.7 Expert Panel Validation
7.8 Currency Conversion
7.9 Contact Us
7.10 Disclaimer

1.1 List of Tables
Table 1: Diabetes Care Devices, Ireland, Overall Revenue ($m), USD Actual, 2003-2017
Table 2: Diabetes Care Devices, Ireland, Overall Revenue ($m), USD Actual, Historic, 2003-2010
Table 3: Diabetes Care Devices, Ireland, Overall Revenue ($m), USD Actual, Forecast, 2010-2017
Table 4: Diabetes Care Devices, Ireland, Category Volume (Units), 2003-2017
Table 5: Diabetes Care Devices, Ireland, Category Volume (Units), Historic, 2003-2010
Table 6: Diabetes Care Devices, Ireland, Category Volume (Units), Forecast, 2010-2017
Table 7: Diabetes Care Devices, Ireland, Company Share by Revenue ($m), USD Actual, 2009-2010
Table 8: Glucose Monitoring, Ireland, Revenue ($m), USD Actual by Segment, Historic, 2003-2010
Table 9: Glucose Monitoring, Ireland, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017
Table 10: Blood Glucose Meters, Ireland, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010
Table 11: Blood Glucose Meters, Ireland, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017
Table 12: Glucose Monitoring, Ireland, Volume (Units) by Segment, Historic, 2003-2010
Table 13: Glucose Monitoring, Ireland, Volume (Units) by Segment, Forecast, 2010-2017
Table 14: Blood Glucose Meters, Ireland, Volume (Units) by Sub-Segment, Historic, 2003-2010
Table 15: Blood Glucose Meters, Ireland, Volume (Units) by Sub-Segment, Forecast, 2010-2017
Table 16: Glucose Monitoring, Ireland, Average Price ($), Historic, 2003-2010
Table 17: Glucose Monitoring, Ireland, Average Price ($), Forecast, 2010-2017
Table 18: Glucose Monitoring, Ireland, Distribution Share by Revenue ($m), USD Actual, 2009-2010
Table 19: Glucose Monitoring, Ireland, Company Share by Revenue ($m), USD Actual 2009-2010
Table 20: Insulin Delivery, Ireland, Revenue ($m), USD Actual by Segment, Historic, 2003-2010
Table 21: Insulin Delivery, Ireland, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017
Table 22: Insulin Pens, Ireland, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010
Table 23: Insulin Pens, Ireland, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017
Table 24: Insulin Pumps (Traditional Insulin Pumps), Ireland, Revenue ($m), USD Actual, Historic, 2003-2010
Table 25: Insulin Pumps (Traditional Insulin Pumps), Ireland, Revenue ($m), USD Actual, Forecast, 2010-2017
Table 26: Insulin Delivery, Ireland, Volume (Units) by Segment, Historic, 2003-2010
Table 27: Insulin Delivery, Ireland, Volume (Units) by Segment, Forecast, 2010-2017
Table 28: Insulin Pens, Ireland, Volume (Units) by Sub-Segment, Historic, 2003-2010
Table 29: Insulin Pens, Ireland, Volume (Units) by Sub-Segment, Forecast, 2010-2017
Table 30: Insulin Pumps (Traditional Insulin Pumps), Ireland, Volume (Units), Historic, 2003-2010
Table 31: Insulin Pumps (Traditional Insulin Pumps), Ireland, Volume (Units), Forecast, 2010-2017
Table 32: Insulin Delivery, Ireland, Average Price ($), Historic, 2003-2010
Table 33: Insulin Delivery, Ireland, Average Price ($), Forecast, 2010-2017
Table 34: Insulin Delivery, Ireland, Distribution Share by Revenue ($m), USD Actual, 2009-2010
Table 35: Insulin Delivery, Ireland, Company Share by Revenue ($m), USD Actual 2009-2010
Table 36: USD to Local Currency, Ireland, Average Actual Rate 2003-2010

1.2 List of Figures
Figure 1: Diabetes Care Devices, Ireland, Overall Revenue ($m), USD Actual, 2003-2017
Figure 2: Diabetes Care Devices, Ireland, Overall Revenue ($m), USD Actual, Historic, 2003-2010
Figure 3: Diabetes Care Devices, Ireland, Overall Revenue ($m), USD Actual, Forecast, 2010-2017
Figure 4: Diabetes Care Devices, Ireland, Category Volume (Units), 2003-2017
Figure 5: Diabetes Care Devices, Ireland, Category Volume (Units), Historic, 2003-2010
Figure 6: Diabetes Care Devices, Ireland, Category Volume (Units), Forecast, 2010-2017
Figure 7: Diabetes Care Devices, Ireland, Company Share (%), 2010
Figure 8: Glucose Monitoring, Ireland, Revenue ($m), USD Actual by Segment, Historic, 2003-2010
Figure 9: Glucose Monitoring, Ireland, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017
Figure 10: Blood Glucose Meters, Ireland, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010
Figure 11: Blood Glucose Meters, Ireland, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017
Figure 12: Glucose Monitoring, Ireland, Volume (Units) by Segment, Historic, 2003-2010
Figure 13: Glucose Monitoring, Ireland, Volume (Units) by Segment, Forecast, 2010-2017
Figure 14: Blood Glucose Meters, Ireland, Volume (Units) by Sub-Segment, Historic, 2003-2010
Figure 15: Blood Glucose Meters, Ireland, Volume (Units) by Sub-Segment, Forecast, 2010-2017
Figure 16: Glucose Monitoring, Ireland, Company Share (%), 2010
Figure 17: Insulin Delivery, Ireland, Revenue ($m), USD Actual by Segment, Historic, 2003-2010
Figure 18: Insulin Delivery, Ireland, Revenue ($m), USD Actual by Segment, Forecast, 2010-2017
Figure 19: Insulin Pens, Ireland, Revenue ($m), USD Actual by Sub-Segment, Historic, 2003-2010
Figure 20: Insulin Pens, Ireland, Revenue ($m), USD Actual by Sub-Segment, Forecast, 2010-2017
Figure 21: Insulin Pumps (Traditional Insulin Pumps), Ireland, Revenue ($m), USD Actual, Historic, 2003-2010
Figure 22: Insulin Pumps (Traditional Insulin Pumps), Ireland, Revenue ($m), USD Actual, Forecast, 2010-2017
Figure 23: Insulin Delivery, Ireland, Volume (Units) by Segment, Historic, 2003-2010
Figure 24: Insulin Delivery, Ireland, Volume (Units) by Segment, Forecast, 2010-2017
Figure 25: Insulin Pens, Ireland, Volume (Units) by Sub-Segment, Historic, 2003-2010
Figure 26: Insulin Pens, Ireland, Volume (Units) by Sub-Segment, Forecast, 2010-2017
Figure 27: Insulin Pumps (Traditional Insulin Pumps), Ireland, Volume (Units), Historic, 2003-2010
Figure 28: Insulin Pumps (Traditional Insulin Pumps), Ireland, Volume (Units), Forecast, 2010-2017
Figure 29: Insulin Delivery, Ireland, Company Share (%), 2010
Figure 30: Global Markets Direct Methodology

F. Hoffmann-La Roche Ltd.
LifeScan, Inc.
Sanofi
Novo Nordisk A/S
Eli Lilly and Company
Bayer HealthCare AG
Abbott Laboratories
Medtronic, Inc.
NIPRO CORPORATION
Becton, Dickinson and Company
Terumo Corporation
Animas Corporation

Customers who bought this item also bought

• Ireland In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2017
• Ireland Diagnostic Imaging Investment Opportunities, Analysis and Forecasts to 2017
• Ireland In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2018
• Ireland Diagnostic Imaging Investment Opportunities, Analysis and Forecasts to 2018
• The Top 100 Distributors Of IVD Reagents, Instruments & Accessories In Europe
• Medical Device Market in Ireland - Market Size, Forecasts and Market Players
• Plasters and Bandages Market in Ireland to 2014 (OTC Healthcare)
• First Aid Kits Market in Ireland to 2014 (OTC Healthcare)
• The Top 25 Israeli Developers Of Patient Monitoring Systems
• Incontinence in Ireland